ABSTRACT
Limited information exists on the use of zinc-l-selenomethionine (Zn-L-SeMet) in broiler diets and its effects on the growth performance, body temperature, mortality rates, blood profile, and gene expression, especially when animals are reared under cyclic heat stress conditions. This study aimed to investigate the impact of Zn-L-SeMet in broiler diets from 1 to 42 days of age reared under cyclic heat stress and its effects on growth performance, cloacal temperatures, mortality rate, blood parameters, and insulin-like growth factor 1 (IGF-1) and growth hormone receptor (GHR) gene expression in the breast muscle. A total of 1000 male Cobb 500® broiler chicks were randomly assigned to five treatments: 0, 0.15, 0.23, 0.47, and 1.30 mg/kg of Zn-L-SeMet. Each treatment consisted of 10 replicates with 20 birds each. No statistically significant differences in growth performance were observed from 1 to 21 days of age (P > 0.05). However, from 1 to 42 days, feed intake (FI) and feed conversion ratio (FCR) decreased linearly (P < 0.05). Cloacal temperatures showed no significant effects (P > 0.05), while overall mortality rate exhibited a quadratic response (P < 0.05), with the optimal inclusion level predicted to reduce broiler mortality at 0.71 mg/kg. Triglyceride (TRG) levels increased with 0.97 mg/kg (P < 0.05), and gama-glutamil transferase (GGT) levels decreased with the inclusion of 1.19 mg/kg (P < 0.05). No significant effects on IGF-1 and GHR gene expression were found (P > 0.05). In conclusion, the inclusion of 1.30 mg/kg of Zn-L-SeMet in diets of heat-stressed broilers improved growth performance from 1 to 42 days of age. An inclusion of 0.71 mg/kg reduced mortality rate, while 0.97 mg and 1.19 mg increased and reduced TRG and GGT levels, respectively.
Subject(s)
Selenomethionine , Zinc , Animals , Male , Selenomethionine/metabolism , Chickens , Dietary Supplements , Insulin-Like Growth Factor I/metabolism , Diet/veterinary , Heat-Shock Response , Animal Feed/analysisABSTRACT
Total selenium (Se) and Se species concentrations were determined in 50 infant formulas and milk samples commercialized in Brazil and Belgium. Infant formula categories were starter, follow-up, specialized and plant-based (soy and rice), while milk samples included whole, skimmed, semi-skimmed and plant-based products. Total Se content was determined by Inductively Coupled Plasma Mass Spectrometry (ICP-MS), after microwave digestion. An enzymatic extraction method was applied to evaluate the Se species, mostly selenomethionine (SeMet), Se(IV) and Se(VI), through High Performance Liquid Chromatography coupled to ICP-MS (LC-ICP-MS). Starters and follow-up samples presented the highest total Se concentrations and values up to 30 µg/kg were observed in the reconstituted product. The lowest level (below the LOQ = 10 µg/kg) was verified in an anti-regurgitation specialized formula. The relative agreement between the measured total Se and the Se content declared on the label varied from 55 % to 317 %. Concentrations in infant formulas were not markedly different from concentrations in milk except for rice and oat milk samples that showed values below the LOQ. SeMet was the main species found in milks, while in infant formulas the species concentrations varied according to the product. The daily intake (DI) of Se via infant formula consumption was calculated and compared with the Adequate Intake (AI) value and the Dietary Reference Intake (DRI) established by the EFSA NDA Panel and ANVISA, respectively. Estimated maximum intakes of total Se obtained for reconstituted infant formula were 40.6 mg/day, corresponding to 400 % and 202 % of the DRI and AI, respectively.
Subject(s)
Selenium , Humans , Infant , Animals , Selenium/analysis , Infant Formula/analysis , Brazil , Belgium , Milk/chemistry , Selenomethionine/analysisABSTRACT
Selenium (Se) is an essential micronutrient known to play an important role in the antioxidant system that can potentially influence tumor growth. We aimed to investigate the effects of dietary Se supplementation after detection of 4T1 mammary tumor growth in BALB/c mice. Thirty female mice received subcutaneous inoculation of 4T1 cells. After five days, all animals presenting palpable tumors were randomly assigned to three groups: a control group (Se-control) receiving a diet with adequate Se (0.15 mg/kg) and two other groups that received Se-supplemented diets (1.4 mg/kg of total Se) with either Brazilian nuts (Se-Nuts) or selenomethionine (SeMet). Data were assessed by either One or Two-way ANOVA followed by Tukey's HSD or Bonferroni's post hoc tests, respectively. Both Se-supplemented diets reduced tumor volume from the thirteenth day of feeding compared with the Se-adequate (control) diet (p < 0.05). The SeMet group presented a higher Se blood concentration (p < 0.05) than the Se-control group, with the Se-Nuts group presenting intermediate values. Selenoprotein P gene expression in the liver was higher in the Se-Nuts group than in the Se-control group (p < 0.05), while the SeMet group presented intermediate expression. Dietary Se supplementation, starting after detection of 4T1 palpable lesions, reduced tumor volume in mice.
Subject(s)
Bertholletia , Mammary Neoplasms, Animal , Selenium , Female , Animals , Mice , Selenium/pharmacology , Selenomethionine/pharmacology , Dietary Supplements , Diet , Mammary Neoplasms, Animal/drug therapyABSTRACT
Oxidative stress significantly compromises the production efficiency of laying hens. It has been reported in literature that selenium (Se) in poultry diets has a positive effect on mitigating these effects. This study has been carried out to evaluate the effects of Se supplementation in feeds, from either an inorganic or a hydroxy-selenomethionine (OH-SeMet) source, on the performance and physiological traits of 50- to 70-wk-old Dekalb Brown laying hens under heat stress, and on their egg quality after different storage durations. The treatments consisted in supplementing 0.3 ppm of Se as sodium selenite (SS; 45%-0.7g/ton) or OH-SeMet (2%-15g/ton) in twelve 16-bird replicates. Supplementation with OH-SeMet resulted in a better performance of the laying hens than with SS: -5% feed conversion ratio and +3.6% of egg mass. A reduction in egg quality was observed with prolonged egg storage, which was mitigated with the use of OH-SeMet in laying hen diets. The use of OH-SeMet increased the antioxidant capacity of the birds, which showed higher glutathione peroxidase levels in the blood, kidneys, liver, and intestinal mucosa, in addition to a higher Se content in the eggs and a greater bone resistance. Thus, supplementing feeds with 0.3 ppm of OH-SeMet to 50- to 70-wk-old semi-heavy laying hens enhances their antioxidant capacity and leads to a higher egg quality and productivity than SS supplementation.
Subject(s)
Selenium , Selenomethionine , Animals , Female , Selenomethionine/pharmacology , Antioxidants , Chickens , Ovum , Selenium/pharmacology , Diet/veterinary , Heat-Shock Response , Animal Feed/analysis , Dietary SupplementsABSTRACT
A successful mushroom enrichment process must produce foods that have compounds potentially absorbed by the human body. In this study, Pleurotus ostreatus and Pleurotus djamor mushrooms were grown on organic substrate supplemented with different Se(IV) and Se(VI) concentrations, and evaluated in the following features: Fruiting bodies morphology; Se uptake and accumulation; Distribution of proteins and protein-bound Se; Se species identification on enzymatic extracts; Se bioaccessibility; and Distribution of bioaccessible protein-bound Se. Pleurotus djamor grown on Se(IV)-supplemented substrate showed the greatest potential to uptake and accumulate Se. For Se species screening, selenomethionine was identified in white oyster mushroom, while selenomethionine, selenocystine, and Se-methylselenocysteine in pink oyster mushrooms. In soluble fractions from in vitro gastrointestinal digestion assays, Se showed high bioaccessibility (>94%). Lastly, bioaccessible Se species were found to be mainly associated to LMW (<17 kDa) in Pleurotus ostreatus (74%) and Pleurotus djamor (68%) grown on Se(IV)-supplemented substrates.
Subject(s)
Agaricales , Pleurotus , Agaricales/chemistry , Dietary Supplements , Humans , Pleurotus/chemistry , Selenomethionine/metabolismABSTRACT
This study aimed to compare different selenium (Se) sources in the diet on boar's semen quality and fertility. For this, 28 boars aged 8 to 28 mo were fed with the following dietary treatments for 95 d: 0.3 mg Se/kg as sodium selenite (SS; n = 14) and 0.3 mg Se/kg as hydroxy-selenomethionine (OH-SeMet; n = 14). During this period, two experiments were carried out. In experiment 1, the semen of all boars was evaluated every 2 wk. Raw semen was initially evaluated for the processing of seminal doses, which were stored at 17 °C for 72 h, followed by sperm quality assessments. Furthermore, Se concentration and glutathione peroxidase (GPx) activity were measured in the seminal plasma. In experiment 2, 728 females were inseminated weekly with seminal doses from boars of the different experimental groups to further assess in vivo fertility and litter characteristics. Results demonstrated that boars fed OH-SeMet had more Se in their seminal plasma (P < 0.05), showing the greater bioavailability of the organic source in the male reproductive system. Moreover, boars fed OH-SeMet tended (P < 0.10) toward a higher total sperm count in the ejaculate (66.60 vs. 56.57 × 109 sperm) and the number of seminal doses (22.11 vs. 18.86; 3 × 109 sperm/dose) when compared with those fed SS. No effect of the dietary treatments was observed on GPx activity in seminal plasma (P > 0.05) as well as on raw and stored semen quality (P > 0.05). Under in vivo conditions, seminal doses from boars fed OH-SeMet tended (P < 0.10) toward a higher pregnancy rate at weeks 3, 5, and 8, and also resulted in a higher (P < 0.05) percentage of pregnant females in the overall period (99.30 vs. 97.00). In conclusion, the replacement of SS with OH-SeMet in boars' diet can improve sperm production and results in better reproductive performance for them, bringing greater productivity and profitability to artificial insemination centers and commercial pig farms.
Subject(s)
Selenium , Animals , Diet/veterinary , Female , Insemination, Artificial/veterinary , Male , Pregnancy , Selenomethionine , Semen , Semen Analysis/veterinary , Sperm Motility , Spermatozoa , SwineABSTRACT
Selenium is an essential element in human and animal metabolism integrated into the catalytic site of glutathione peroxidase (GPX1), an antioxidant enzyme that protects cells from damage caused by reactive oxygen species (ROS). Oxidative stress refers the imbalance between ROS and antioxidant defense systems. It generates alterations of DNA, proteins and lipid peroxidation. The imbalance occurs particularly during ischemia and lack of postmortem perfusion. This mechanism is of relevance in transplant organs, affecting their survival. The aim of this research is to evaluate the effect of seleno-methionine (SeMet) as a protective agent against postmortem ischemia injury in transplant organs. Wistar rats were orally administered with SeMet. After sacrifice, liver, heart and kidney samples were collected at different postmortem intervals (PMIs). SeMet administration produced a significant increase of Se concentration in the liver (65%, p < 0.001), heart (40%, p < 0.01) and kidneys (45%, p < 0.05). Levels of the oxidative stress marker malondialdehyde (MDA) decreased significantly compared to control in the heart (0.21 ± 0.04 vs. 0.12 ± 0.02 mmol g-1) and kidneys (0.41 ± 0.02 vs. 0.24 ± 0.03 mmol g-1) in a PMI of 1-12 h (p < 0.01). After SeMet administration for 21 days, a significant increase in GPX1 activity was observed in the liver (80%, p < 0.001), kidneys (74%, p < 0.01) and heart (35%, p < 0.05). SeMet administration to rats significantly decreased the oxidative stress in the heart, liver and kidneys of rats generated by postmortem ischemia.
Subject(s)
Heart , Ischemia/metabolism , Kidney/metabolism , Liver/metabolism , Selenomethionine/metabolism , Administration, Oral , Animals , Female , Oxidative Stress , Rats , Rats, Wistar , Selenomethionine/administration & dosage , Selenomethionine/analysisABSTRACT
Although the chemical characteristics of selenomethionine (SeMet) are similar to those of methionine (Met), the physiological activity of SeMet apparently differs in its ability to stimulate ethylene production in plant tissues. Since selenium alters root architecture of rice seedlings by modifying ethylene production, the investigation of the effect of SeMet and Met on rice growth would be a step forward towards unraveling factors that underlie selenium toxicity. Here, we report that SeMet increased concentrations of reactive oxygen species (ROS), inhibiting auxin and increasing ethylene production in rice seedlings. The effect of SeMet on seedlings was mediated by the inhibition of the abundance of transcripts encoding auxin transport and cell expansion proteins. Moreover, SeMet led to increased seedling respiration, which was positively correlated with organic acids consumption, but negatively with sugars consumption, thereby decreasing seedling growth. In contrast with SeMet treatment, Met did not affect ROS production, hormone biosynthesis and seedling growth, indicating an exclusive selenium effect. The singlet oxygen scavenger, 1,4-diazabicyclooctane, overrode the repressive effect of SeMet in seedling growth. Our results demonstrate a phytotoxic effect of SeMet for rice seedlings and reveal a relationship between reactive oxygen species, hormone homeostasis and carbon availability, which regulates growth responses.
Subject(s)
Oryza/drug effects , Oxidative Stress , Selenomethionine/toxicity , Antioxidants/metabolism , Ethylenes/biosynthesis , Indoleacetic Acids/metabolism , Methionine/pharmacology , Oryza/growth & development , Oryza/metabolism , Plant Growth Regulators/biosynthesis , Reactive Oxygen Species/metabolism , Seedlings/drug effects , Seedlings/growth & development , Seedlings/metabolismABSTRACT
The objective of this study was to determine whether supplementing the diets of laying hens with selenomethionine (SM, 1% selenium) improves performance and egg quality. We supplemented diets with SM as follows: T0 control (without SM); T5, T10, T15, and T20 were supplemented with 5, 10, 15, and 20 mg of SM/kg of feed, respectively (equal to 0.05, 0.10, 0.15, and 0.20 mg selenium/kg of feed). T5 and T10 hens showed better feed conversion per kg of egg, percentage of laying, higher daily feed intake, and higher average egg weight. The eggs of hens supplemented with SM had lower levels of lipoperoxidation (LPO) in fresh (T15 and T20) and stored eggs (T20). Glutathione peroxidase (GPx) and superoxide dismutase (SOD) activities, as well as total antioxidant capacity were greater in egg yolks after storage (T10; T15; T20 compared to T0). Hens supplemented with SM had elevated GPx and SOD activities and decreased oxidative reactions. PRACTICAL APPLICATIONS: Selenium has several nutraceutical properties, with beneficial effects on the health of the animal and the food produced from them (eggs, in this case). Selenomethionine supplementation in the diet of laying hens improves productive efficiency, stimulates the antioxidant system and reduces lipid peroxidation in the egg yolk. Egg-laying hens that received selenomethionine showed minimized lipid peroxidation in stored eggs, possibly improving shelf life of the eggs.
Subject(s)
Chickens/metabolism , Eggs/analysis , Selenomethionine/administration & dosage , Animal Feed/analysis , Animals , Antioxidants , Dietary Supplements/analysis , Egg Yolk/chemistry , Female , Food Storage , Glutathione Peroxidase/metabolism , Lipid Peroxidation/drug effects , Selenium/analysis , Superoxide Dismutase/metabolismABSTRACT
The aim of the study was to verify the influence of selenomethionine (SM) supplementation on performance, carcass yield, characteristics of meat quality and Se tissue deposition of finishing pigs. A total of 128 hybrid pigs with an average weight of 76 kg were distributed in randomized blocks according to body weight in eight treatments and eight replicates. The experimental treatments were two Se levels from sodium selenite-SS (0.3 and 0.6 ppm), four Se levels from SM (0.3, 0.4, 0.5 and 0.6 ppm) and two combinations of SS with SM (SS 0.15 + SM 0.15 ppm and SS 0.3 + SM 0.3 ppm) providing 0.3 and 0.6 ppm Se in the diet respectively. The feeds were based on corn and soya bean meal. After 30 days on test, were analysed the performance indices and the pigs were slaughtered at commercial slaughterhouse. The cold carcass yield, the physicochemical characteristics of the loin meat and the Se content in muscle and liver were evaluated. There was no significant difference in performance indices (p > .05); however, there was a linear effect on the increase in pig carcass yield by increasing SM (p < .05). The use of SM solely or combined with SS provided higher Se deposition in muscle compared to SS (p < .05). The highest Se deposition in muscle occurred for SM at 0.4 ppm (p < .05). The SS provided higher Se deposition in liver (p < .05). The SM presented best results for meat quality compared to other sources (p < .05). The level of 0.4 ppm Se promoted the best results for the indices of yellow, luminosity, cooking loss and pH (p < .05). The use of SM at any level promotes higher oxidation stability of pig meat (p < .05). The supplementation of SM at a level of 0.4 ppm promotes better physicochemical characteristics and higher Se deposition on swine meat.
Subject(s)
Animal Feed/analysis , Diet/veterinary , Meat/standards , Selenium/metabolism , Selenomethionine/pharmacology , Animal Nutritional Physiological Phenomena , Animals , Cooking , Lipid Peroxidation , Selenium/chemistry , Swine , Tissue DistributionABSTRACT
The aim of the present study was to verify the effect of selenomethionine (SM) supplementation in the diet of chickens on performance, carcass yield, apparent retention, meat quality, and selenium (Se) deposition in tissues. In the first experiment, 2,100 day-old male chicks from the Hubbard Flex strain were randomly distributed in 84 plots with 12 treatments and 7 replicates. The treatments consisted of SM (1,600 ppm) supplementation at levels of 0.3 and 0.5 ppm in substitution of sodium selenite (45.7%) in different preslaughter phases. In the second experiment, 224 day-old male chicks from Hubbard Flex strain were randomly distributed in 28 metabolic cages. Poultry were distributed in 4 treatments with 7 replicates (8 poultry) in the experimental period from 1 to 21 D and experimental plot with 4 poultry aged from 22 to 42 D. Treatments consisted of 4 SM addition levels (0.3, 0.4, 0.5, and 0.6 ppm). In both experiments, the performance (1 to 21 and 1 to 42 D), carcass yield and cuts, apparent retention of Se (33 to 35 D), physical and chemical characteristics of the breast meat were evaluated: objective color, drip loss (DL), cooking loss (CL), pH, peroxide value, and Se deposition in tissues. In experiment I, it was found that SM at 0.3 ppm improved the weight gain and feed conversion of 1 to 42 D. The use of SM at 0.5 ppm resulted in lower DL and CL. The highest Se deposition in muscles was obtained using the SM at 0.5 ppm of 1 to 42 D. Using the SM at 0.5 ppm, only in the last week there was a deposition similar to the use of SM at 0.3 ppm of 1 to 42 D. In experiment II, it can be observed that increased SM levels provided lower DL and lower pH values. Se deposition in tissues of broiler chickens increased linearly at the SM level from 0.3 to 0.6 ppm.
Subject(s)
Chickens/physiology , Meat/analysis , Selenium/metabolism , Selenomethionine/metabolism , Age Factors , Animal Feed/analysis , Animals , Diet/veterinary , Dietary Supplements/analysis , Dose-Response Relationship, Drug , Male , Random Allocation , Selenomethionine/administration & dosage , Tissue DistributionABSTRACT
The aim of this study was to determine the effects of supplementing close-up and fresh dairy cows diets with sodium selenite or organic sources of selenium (Se) on the serum biochemical parameters and antioxidant indicators and Se status. Twenty-four multiparous Holstein dairy cows were balanced by body condition score (BCS), previous lactation milk yield and expected calving date and randomly assigned to 1 of 4 experimental treatments. Treatments were: control (basal diet without Se supplementation), sodium selenite supplementation (0.50 mg of Se kg-1 DM; Se-S), selenium yeast supplementation (0.50 mg of Se kg-1 DM; Se-Y) and selenomethionine supplementation (0.50 mg of Se kg1 DM; Se-M). Serum Se concentrations were higher for cows in Se-Y (72.34 µg dL-1 ) and Se-Met (72.34 µg dL-1 ) than control (59.93µg/dl) and Se-S (64.79µg/dl). The Se supplementation and sources did not affect serum metabolites or indices of antioxidant pre and postpartum, except serum total protein and albumin concentrations. Cows in Se-M had greater serum total protein and albumin concentrations than those in control. The results of present study showed that serum Se concentrations increased in Se-Y and SeM more effectively than Se-S, indicating that selenomethionine could replace Se-S as an effective organic Se source for transition dairy cows.(AU)
Subject(s)
Animals , Female , Cattle , Selenium Compounds/chemistry , Selenium Compounds/metabolism , Antioxidants/chemistry , Chemistry, Bioinorganic , Selenomethionine/chemistry , Thyroid Hormones/analysisABSTRACT
The aim of this study was to determine the effects of supplementing close-up and fresh dairy cows diets with sodium selenite or organic sources of selenium (Se) on the serum biochemical parameters and antioxidant indicators and Se status. Twenty-four multiparous Holstein dairy cows were balanced by body condition score (BCS), previous lactation milk yield and expected calving date and randomly assigned to 1 of 4 experimental treatments. Treatments were: control (basal diet without Se supplementation), sodium selenite supplementation (0.50 mg of Se kg-1 DM; Se-S), selenium yeast supplementation (0.50 mg of Se kg-1 DM; Se-Y) and selenomethionine supplementation (0.50 mg of Se kg1 DM; Se-M). Serum Se concentrations were higher for cows in Se-Y (72.34 µg dL-1 ) and Se-Met (72.34 µg dL-1 ) than control (59.93µg/dl) and Se-S (64.79µg/dl). The Se supplementation and sources did not affect serum metabolites or indices of antioxidant pre and postpartum, except serum total protein and albumin concentrations. Cows in Se-M had greater serum total protein and albumin concentrations than those in control. The results of present study showed that serum Se concentrations increased in Se-Y and SeM more effectively than Se-S, indicating that selenomethionine could replace Se-S as an effective organic Se source for transition dairy cows.
Subject(s)
Female , Animals , Cattle , Antioxidants/chemistry , Selenium Compounds/metabolism , Selenium Compounds/chemistry , Chemistry, Bioinorganic , Selenomethionine/chemistry , Thyroid Hormones/analysisABSTRACT
Superoxide-hydrogen peroxide (S-HP) imbalance genetically caused by a gene polymorphism in the human manganese superoxide dismutase enzyme (Val16Ala-MnSOD) is associated with several diseases. Into mitochondria, MnSOD catalyses superoxide radical producing HP and oxygen. Ala-MnSOD genotype presents a high MnSOD efficiency and generates the highest HP concentrations that has been associated with the risk of several cancer types. Cellular selenoenzymes glutathione peroxidase and thioredoxin reductase (TrxR) and catalase (CAT) are essential to HP removal produced in excess in cells. Since, synthesis and activities of selenoenzymes are selenium dependent, we hypothesized that AA-MnSOD cells could have an improvement on antioxidant status undergoing Seleno-L-methionine (SeMet) treatment. This study performed an in vitro protocol to evaluate the response of peripheral blood mononuclear cells (PBMC) carriers of different Val16Ala-MnSOD genotypes exposed to SeMet. SeMet effects on cell viability, apoptosis induction and modulation of oxidative variables were determined using spectrophotometric, flow cytometry, fluorimetric and immunoassays. Gene modulation of antioxidant enzymes was also performed by qRT-PCR. From an initial protocol using heterozygous (AV) cells was determined that 1nM SeMet presented a cytoprotective effect. However, whereas this concentration did not change AA viability, in VV cells it was cytotoxic by increasing necrosis events. SeMet induced higher selenoenzymes levels in AA and VV cells and decreased oxidative markers levels including DNA damage. The results suggest a pharmacogenetic positive response of SeMet effect on AA-cells. Future studies in vivo could be essential to evaluate the potential clinical impact of S-HP imbalance after use of foods or supplements containing SeMet.
Subject(s)
Hydrogen Peroxide/metabolism , Leukocytes, Mononuclear/drug effects , Polymorphism, Genetic , Selenomethionine/pharmacology , Superoxide Dismutase/genetics , Superoxides/metabolism , Apoptosis/drug effects , Cell Survival/drug effects , Cells, Cultured , Dose-Response Relationship, Drug , Humans , Leukocytes, Mononuclear/metabolism , Oxidative Stress/drug effects , Selenomethionine/administration & dosage , Structure-Activity Relationship , Superoxide Dismutase/metabolismABSTRACT
PURPOSE: To analyze the impact of selenium supplementation on serum antiTPO levels and thyroid echogenicity in patients with CAT, evaluating the response in subgroups with different GPx1 genotypes. METHODS: CAT patients (n = 55) with positive antiTPO were randomized to selenomethionine (SeMet) 200 µg daily (n = 28) or placebo (n = 27) for 3 months. Assessments included GPx1 genotyping at baseline and serum levels of plasma selenium, erythrocyte GPx1 activity, antiTPO and thyroid echogenicity at baseline, and 3 and 6 months. RESULTS: In the SeMet group, the increase in plasma levels of selenium and erythrocyte GPx1 activity was similar among patients with different GPx1 genotypes. In the overall cohort, patients randomized to SeMet showed a 5 % decrease in antiTPO levels at 3 months (p = non-significant) and 20 % at 6 months (p < 0.001 versus 3 months). In contrast, patients in the placebo group did not show significant changes in antiTPO levels at any time point. Subgroup analysis showed that patients with different GPx1 genotypes presented comparable responses in antiTPO levels and echogenicity index to SeMet. CONCLUSIONS: Selenium supplementation decreased serum antiTPO levels in CAT patients, with similar response among patients with different GPx1 genotypes.
Subject(s)
Autoimmunity/drug effects , Dietary Supplements , Glutathione Peroxidase/genetics , Iodide Peroxidase/immunology , Selenomethionine/therapeutic use , Thyroid Gland/drug effects , Thyroiditis, Autoimmune/drug therapy , Adult , Double-Blind Method , Female , Genotype , Humans , Inflammation/drug therapy , Inflammation/genetics , Inflammation/immunology , Male , Middle Aged , Selenomethionine/administration & dosage , Thyroid Gland/immunology , Thyroiditis, Autoimmune/genetics , Thyroiditis, Autoimmune/immunology , Treatment Outcome , Young Adult , Glutathione Peroxidase GPX1ABSTRACT
The comparative structural modeling of djenkolic acid and its derivatives containing selenium and tellurium in chalcogen sites (Ch=Se, Te) has provided detailed information about the bond lengths and bond angles, filling the gap in what we know about the structural characteristics of these aminoacids. The investigation using the molecular mechanics technique with good approximation confirmed the available information on X-ray refinements for the related compounds methionine and selenomethionine, as well as for an estimate made earlier for telluromethionine. It was shown that the Ch-C(3) and Ch-C(4) bond lengths grow in parallel with the increasing anionic radii. Although the distances C-C, C-O, and C-N are very similar, the geometry of conformers is quite different owing to the possibility of rotation about four carbon atoms, hence the remarkable variability observed in dihedral angles. It was shown that the compounds contain a rigid block with two Ch atoms connected through a methylene group. The standard program Gaussian 03 with graphical interface Gaussview 4.1.2 has proved to be satisfactory tool for the structural description of less-common bioactive compositions when direct X-ray results are absent.
Subject(s)
Cysteine/analogs & derivatives , Selenium/chemistry , Sulfur/chemistry , Tellurium/chemistry , Crystallography, X-Ray , Cysteine/chemistry , Methionine/analogs & derivatives , Methionine/chemistry , Models, Molecular , Molecular Structure , Selenomethionine/chemistryABSTRACT
This study describes a method for seleno-amino acids determination in Argentinean olive oils. Preliminary total selenium determination in olive oils probed low concentrations (62.8±1.6 to 117.4±3.0 µg/kg) and the necessity of implementing a preconcentration method. To this end a XAD® resin was employed as sorbent for selenomethionine (Se-Met), selenomethylselenocysteine (Se-MetSeCys), and selenocysteine (Se-Cys) preconcentration. Determinations were performed by UPLC-ESI-MS/MS. Recoveries were between 84% and 97% for the seleno-amino acids studied, reaching a detection limit of 0.09 µg/kg, a precision of 10% (RSD, n=6), and an enhancement factor of 60-fold (6 for the extraction system and 10 for the preconcentration approach). The only detected Se species in the olive oils was Se-MetSeCys in concentrations ranging from 2.0 to 8.3 µg/kg.
Subject(s)
Plant Oils/analysis , Selenocysteine/analogs & derivatives , Selenomethionine/analysis , Chromatography, High Pressure Liquid , Limit of Detection , Olive Oil , Polystyrenes/chemistry , Polyvinyls/chemistry , Selenocysteine/analysis , Solid Phase Extraction , Spectrometry, Mass, Electrospray Ionization , Tandem Mass Spectrometry/methodsABSTRACT
Contexto: Pacientes com tireoidite autoimune crônica com anticorpos de peroxidase tireoideana (Anti-TPO) podem progredir para hipotireoidismo subclínico e clínico. Estudos anteriores mostraram uma redução no anti-TPO em pacientes com hipotireoidismo que receberam tratamento de reposição de LT4 e suplementação de selênio. Objetivos: Avaliar se a selenometionina (SeMet) reduz o anti-TPO em pacientes anti-TPO positivos eutireoideos tratados com LT4 e melhora a ecogenecidade da tireoide em comparação com grupo de pacientes tratados com placebo. Desenho: Estudo duplo-cego aleatório controlado com placebo. Pacientes e métodos: Um total de 55 pacientes consecutivos com TCA (50 mulheres, 5 homens, idade mediana de 48 anos variando de 20 a 58), 4 tabagistas, 4 anos desde o diagnóstico da doença (mediana), com TSH normal ou levemente elevado, T4L dentro dos níveis normais, anti-TPO maior que 100 U/ml foram aleatoriamente selecionados para receber uma dose diária de 200 ?g de selenometionina (grupo SeMet; n = 28) ou placebo (grupo P; n = 27) por 3 meses. Anticorpos da tireoperoxidase e tireoglobulina (TPO-Ab; TG-Ab), TSH, FT4, T3, T4, proteína C-reativa (PCR), citocinas (IL6, IL10, TNF), glicose sanguínea em jejum, calcitonina, selênio plasmático, concentração de iodo na urina, atividade da peroxidase de glutationa 1 em eritrócitos (GPx1) foram dosados no basal, após 3 e 6 meses de acompanhamento. Polimorfismo do GPx1-Pro198Leu foi avaliado no basal. Foi efetuado ultrassom de tireoide (US) em cada ponto de acompanhamento. Ecogenecidade do tecido foi caracterizada por análise histográfica computadorizada em escala de cinza e expressa como índice de ecogenecidade (EI). A relação entre concentração de Selênio e atividade GPx1 nos eritrócitos foi analisada para cada genótipo. O IE e associações de variáveis clínicas também foram avaliadas. Resultados: Não houve diferenças nas características iniciais (basais) entre o grupo SeMet e P. Selênio plasmático...
Context: Autoimmune chronic thyroiditis (ACT) euthyroid subjects with positive thyroid peroxidase antibodies (TPO-Ab) may progress to subclinical and overt autoimmune hypothyroidism. Previous studies have shown a decrease in TPO-Ab in hypothyroid patients receiving LT4 replacement therapy plus selenium supplementation. Objectives: To evaluate in euthyroid TPOAb-positive LT4-treated subjects whether selenometionine (SeMet) decreases TPO-Ab and improves thyroid ecogenicity in comparison with placebo. Design: Randomized, placebo-controlled, double-blind study. Patients and methods: A total of 55 consecutive patients with ACT (50 F, 5 M, age median: 48, range: 20-58 years), 4 smokers, duration of disease (median) 4 years, normal or slightly elevated TSH and FT4 within the normal range, TPO-Ab >= 100 U/mL were randomized to receive 200 ?g selenometionine daily ((group SeMet; n = 28) or placebo (group P; n = 27) for 3 months. Thyroperoxidase and thyroglobulin autoantibodies (TPO-Ab; TG-Ab), TSH, FT4, T3, T4, C-reactive protein (CRP), cytokines (IL6, IL10, TNF), fasting blood glucose, calcitonin, plasma selenium, urine iodine concentrations, activity of glutathione peroxidase 1 in erythrocytes (GPx1) were estimated at baseline, after 3 and 6 months of follow-up; GPx1-Pro198Leu polymorphism was assessed at baseline. Thyroid ultrasound (US) was performed at each follow-up point. Tissue ecogenicity was characterized by computerized grey-scale histographic analysis and expressed as ecogenicity index (EI). The relationship between Se concentration and GPx1 erytrocyte activity was analysed for each genotype group. EI and clinical variables associations were also evaluated. Results: There were no differences in baseline characteristics between the SeMet group and the P group. During SeMet supplementation, plasma Se and GPx1 activity did not change in the P group, but increased in the SeMet group. TPO-Ab, anti-TG, TSH and thyroid hormones did not change significantly...
Subject(s)
Humans , Male , Female , Young Adult , Middle Aged , Autoimmunity , Thyroid Gland , Hashimoto Disease , Hypothyroidism , Selenomethionine , ThyroiditisABSTRACT
Selenium (Se) is an essential component of several major metabolic pathways and controls immune function. Arsenic (As) is a human carcinogen with immunotoxic and genotoxic activities, functioning mainly by producing oxidative stress. Due to the ability of Se to interact with As and to possibly block its toxic effects, we investigated the impact of dietary Se-methionine (Se-Met) supplementation on the toxicity of As exposure in vivo in a mouse model. Sufficient and excess levels of Se-Met (0.2 and 2 ppm, respectively) were fed to C57BL/6N female mice exposed to sodium arsenite (3, 6 and 10 mg/kg) in tap water for 9 days. We observed that As exposure increased Se-Met excretion in the urine. Se-Met supplementation increased the relative liver weight and decreased the concentration of total liver proteins in animals exposed to 10 mg/kg of As. Se-Met supplementation maintained a normal pool of glutathione in the liver and increased glutathione peroxidase concentration, although the lipoperoxidation level was increased by Se-Met even without As exposure. Se-Met supplementation helped to maintain the CD4/CD8 ratio of lymphocytes in the spleen, although it increased the proportion of B cells. Se-Met supplementation prior to As exposure increased the secretion of interleukin-4, IL-12 and interferon-γ and the stimulation index of the spleen cells in in vitro assays. Se-Met intake improved the basal immunological parameters but did not reduce the damage caused by oxidative stress after low-dose As exposure.
Subject(s)
Arsenites/toxicity , Carcinogens/toxicity , Dietary Supplements , Selenomethionine , Sodium Compounds/toxicity , Animals , Arsenic/toxicity , Enzyme Inhibitors/toxicity , Female , Glutathione/metabolism , Humans , Interleukin-12/metabolism , Interleukin-4/metabolism , Liver/metabolism , Liver/pathology , Mice , Oxidative Stress/drug effects , Selenomethionine/pharmacology , Selenomethionine/urine , Spleen/metabolism , Spleen/pathologyABSTRACT
A method based on stir bar sorptive extraction (SBSE) and thermal desorption (TD)-gas chromatography-mass spectrometry (GC-MS) has been optimized for the determination of seleno-methyl-selenocysteine (SeMetSeCys) and selenomethionine (SeMet) in biota samples. Aliquots of freeze-dried tissue, a mixture of protease XIV-lipase and water were sonicated for 2min. After extraction, the extract was separated by centrifugation and subjected to derivatization and SBSE-TD-GC-MS. The parameters affecting derivatization, absorption and desorption steps were investigated. The optimized conditions consist of a derivatization with 40µL of ethyl chloroformate (ECF) in 400µL of a water:ethanol:pyridine (60:32:8) mixture, followed by dilution to 1.5mL of 70g NaClL(-1) in water at neutral pH and an extraction step using 10mm×1mm PDMS stir bar, stirring at 800rpm for 20min at room temperature (23±1°C). Three stir bars were used for the extraction of three different aliquots of the same sample and then placed in a single glass desorption liner and simultaneously desorbed for GC-MS analysis. The desorption step required the following conditions: 300°C (desorption temperature), 6min (desorption time), 50mLmin(-1) (vent flow) and -5°C (cryotrapping temperature). The method provided precise (8.1%) and accurate results in the mgSekg(-1) range (using the selected-ion monitoring-SIM mode) against certified reference material SELM-1 yeast, with recoveries higher than 80% for spiked algae and clams samples.